Efficacy and safety of Viltepso® in Duchenne muscular dystrophy: review of clinical studies
The author presents a literature review on the safety and efficacy of antisense oligonucleotides in the treatment of Duchenne muscular dystrophy using the exon skipping method using Viltepso® (viltolarsen), the only drug of this class registered in Russia, as an example. The analysis of internationa...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2024-11-01
|
| Series: | Русский журнал детской неврологии |
| Subjects: | |
| Online Access: | https://rjdn.abvpress.ru/jour/article/view/485 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|